Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,545 | 2 | 46.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,039 | 4 | 42.5% |
| Food and Beverage | $1,549 | 41 | 10.9% |
| Education | $70.24 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $6,713 | 4 | $0 (2021) |
| CSL Behring | $6,068 | 4 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $364.18 | 4 | $0 (2024) |
| UCB, Inc. | $219.91 | 4 | $0 (2024) |
| Akcea Therapeutics, Inc. | $217.22 | 2 | $0 (2019) |
| Genentech, Inc. | $145.02 | 1 | $0 (2022) |
| Lundbeck LLC | $99.39 | 5 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $60.84 | 4 | $0 (2017) |
| Mallinckrodt LLC | $54.40 | 4 | $0 (2017) |
| Acorda Therapeutics, Inc | $37.77 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.82 | 2 | UCB, Inc. ($75.55) |
| 2023 | $247.07 | 3 | Alexion Pharmaceuticals, Inc. ($131.88) |
| 2022 | $145.02 | 1 | Genentech, Inc. ($145.02) |
| 2021 | $4,429 | 3 | Alnylam Pharmaceuticals Inc. ($4,346) |
| 2020 | $8,382 | 4 | CSL Behring ($6,002) |
| 2019 | $320.99 | 7 | Akcea Therapeutics, Inc. ($217.22) |
| 2018 | $287.09 | 10 | Alexion Pharmaceuticals, Inc. ($118.42) |
| 2017 | $286.97 | 19 | Sunovion Pharmaceuticals Inc. ($60.84) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $75.55 | General |
| Category: Neurology | ||||||
| 01/31/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Rare Disease | ||||||
| 12/07/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $98.27 | General |
| 11/08/2023 | Biogen, Inc. | SPINRAZA (Biological), QALSODY | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Neurology | ||||||
| 11/01/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $131.88 | General |
| Category: Rare Disease | ||||||
| 09/22/2022 | Genentech, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $145.02 | General |
| Category: Neurology | ||||||
| 10/13/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $83.61 | General |
| Category: Immunology | ||||||
| 06/03/2021 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Consulting Fee | Cash or cash equivalent | $4,235.00 | General |
| Category: Genetic Disease | ||||||
| 05/05/2021 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $110.50 | General |
| Category: Genetic Disease | ||||||
| 12/24/2020 | CSL Behring | Privigen (Biological), Hizentra | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $6,001.67 | General |
| Category: Immunology | ||||||
| 12/17/2020 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Consulting Fee | Cash or cash equivalent | $2,310.00 | General |
| Category: Genetic Disease | ||||||
| 11/16/2020 | Alnylam Pharmaceuticals Inc. | — | Education | In-kind items and services | $57.50 | General |
| 02/05/2020 | Mitsubishi Tanabe Pharma America, Inc. | — | Education | In-kind items and services | $12.74 | General |
| 06/13/2019 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: Immunology | ||||||
| 06/05/2019 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $104.72 | General |
| Category: NEUROLOGY | ||||||
| 05/02/2019 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: NEUROLOGY | ||||||
| 04/16/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/02/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13.77 | General |
| Category: PARKINSONS DISEASE | ||||||
| 03/28/2019 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: Immunology | ||||||
| 01/17/2019 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: NEUROLOGY | ||||||
| 11/30/2018 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Immunology | ||||||
| 11/16/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11.96 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 09/27/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12.04 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 08/31/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 341 | 391 | $98,624 | $18,853 |
| 2022 | 9 | 319 | 377 | $97,218 | $18,275 |
| 2021 | 7 | 195 | 235 | $58,005 | $12,083 |
| 2020 | 11 | 363 | 462 | $130,497 | $28,870 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 48 | 48 | $21,244 | $4,509 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 50 | 56 | $18,192 | $3,753 | 20.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 70 | 92 | $17,285 | $2,944 | 17.0% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2023 | 45 | 45 | $10,917 | $2,116 | 19.4% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 30 | 30 | $8,340 | $1,630 | 19.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 17 | $3,528 | $1,040 | 29.5% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 16 | 16 | $6,289 | $1,006 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 19 | $4,475 | $972.04 | 21.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 53 | 68 | $8,354 | $883.52 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 28 | 28 | $12,712 | $2,998 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 30 | 37 | $11,104 | $2,712 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 43 | $8,648 | $2,411 | 27.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 62 | 75 | $16,050 | $2,263 | 14.1% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 34 | 34 | $14,008 | $2,016 | 14.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $7,353 | $2,001 | 27.2% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 25 | 25 | $7,700 | $1,441 | 18.7% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2022 | 31 | 31 | $7,998 | $1,312 | 16.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 64 | 85 | $11,645 | $1,121 | 9.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 24 | $6,182 | $1,827 | 29.6% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2021 | 18 | 18 | $11,082 | $1,785 | 16.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 32 | 42 | $7,539 | $1,550 | 20.6% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 14 | 14 | $9,030 | $1,495 | 16.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 29 | 31 | $5,280 | $1,476 | 28.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $4,956 | $1,324 | 26.7% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2021 | 12 | 12 | $5,356 | $969.68 | 18.1% |
About Dr. Jeffrey Shije, MD
Dr. Jeffrey Shije, MD is a Neurology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1972894095.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Shije, MD has received a total of $14,204 in payments from pharmaceutical and medical device companies, with $105.82 received in 2024. These payments were reported across 49 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($6,545).
As a Medicare-enrolled provider, Shije has provided services to 1,218 Medicare beneficiaries, totaling 1,465 services with total Medicare billing of $78,081. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Phoenix, AZ
- Active Since 04/23/2011
- Last Updated 07/05/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972894095
Products in Payments
- ONPATTRO (Drug) $6,656
- Privigen (Biological) $6,002
- TEGSEDI (Drug) $217.22
- Evrysdi (Drug) $145.02
- SOLIRIS (Biological) $131.88
- SOLIRIS (Drug) $118.42
- NORTHERA (Drug) $99.39
- Soliris (Drug) $83.61
- Rystiggo (Drug) $75.55
- Hizentra (Biological) $66.60
- APTIOM (Drug) $60.84
- ACTHAR (Biological) $54.40
- Neupro (Drug) $46.09
- OXTELLAR XR (Drug) $31.17
- ULTOMIRIS (Biological) $30.27
- COPAXONE (Drug) $30.09
- AMPYRA (Drug) $24.00
- GILENYA (Drug) $23.64
- NUEDEXTA (Drug) $23.48
- SPINRAZA (Biological) $16.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Phoenix
Barry Hendin, Md, MD
Neurology — Payments: $3.0M
Maria Ospina, Md, MD
Neurology — Payments: $1.7M
Dr. Suraj Muley, Md, MD
Neurology — Payments: $1.5M
Steve Chung, M.d, M.D
Neurology — Payments: $993,222
Shafeeq Ladha, M.d, M.D
Neurology — Payments: $712,796
Lori Travis, Md, MD
Neurology — Payments: $705,788